As shown in Table 5 and Figure 6, MGMT promoter unmethylated gliomas exhibited higher MTR3.5 signals compared to MGMT promoter methylated gliomas (mean: 0.01 vs -0.01, p = 0.048) (Supplementary Figure S1F). This evidence concerns the gene MGMT and central nervous system cancer.